On June 9, Thermo Fisher Scientific rose 3.14% in regular trading, trading at $485.8/share, with trading volume of $87.75 million. The stock rebounded sharply from a prior session low of $469.63, driven by continued momentum in the AI-powered life sciences theme.

On the news front, OpenAI previously launched GPT-Rosalind, a new AI model focused on life sciences research, and entered into a collaboration with Thermo Fisher Scientific to integrate the model into various workflows. This partnership has continued to fuel market enthusiasm around AI applications in the life sciences sector. Meanwhile, the broader Life Sciences Tools and Services sector showed strength, with Repligen up 4.27%, Waters up 3.38%, Mettler-Toledo up 2.30%, and Danaher up 2.23%.

It is worth noting that HSBC recently downgraded Thermo Fisher from buy to hold with a reduced price target of $540, down from $670. The current stock price remains below the analyst consensus target of $602.50, suggesting potential upside according to broader Street estimates despite the single-firm downgrade.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)